-
Mashup Score: 0Biological embodiment of educational attainment and future risk of breast cancer: findings from a French prospective cohort - 21 hour(s) ago
Background Women with higher educational attainment have a higher risk of developing breast cancer (BC). Despite the acknowledged impact of reproductive and lifestyle factors, some excess risks remain unexplained. Many studies support the hypothesis that education has a distinctive effect on physiological processes associated with health, independently of known risk factors. Objectives In this study, we aimed to determine whether the biological embodiment of education could be part of the observed social inequalities in BC risk. We focused on biomarkers from several physiological systems examined individually, and jointly through a biological health score (BHS). Design Prospective cohort study. Setting This study, based on a subsample of the French E3N cohort, included women with biological data from four nested case–control studies. Participants The study included 3048 postmenopausal women (17% BC). Main outcome measures We first evaluated the association between educational attainmen
Source: bmjopen.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3
Breast cancer survivors who developed incident myocardial infarction or heart failure exhibited increased risk for adverse oncologic outcomes, according to a population-based cohort study.The findings highlight the importance of prioritizing cardiovascular care for these individuals, researchers concluded.
Source: www.healio.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20
Centre for Oral Immunobiology and Regenerative Medicine, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom Department of Oral Biology and Diagnostic Sciences, The Dental College of Georgia, Augusta University, Augusta, United States Georgia Cancer Center, Augusta University, Augusta, United States Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary
Source: elifesciences.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Connecting the dots - Outlook Magazine - 4 day(s) ago
WashU Medicine physicians at Siteman Cancer Center are recognized nationally for their expertise in leading-edge breast cancer therapies. Nearly 50 specialists in surgery, breast reconstruction, medical oncology and radiation oncology, radiology and pathology are part of the Breast Cancer Program at Siteman, providing personalized treatment plans for patients. Advanced genetic testing, including tests developed by […]
Source: outlook.washu.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Biological embodiment of educational attainment and future risk of breast cancer: findings from a French prospective cohort - 6 day(s) ago
Background Women with higher educational attainment have a higher risk of developing breast cancer (BC). Despite the acknowledged impact of reproductive and lifestyle factors, some excess risks remain unexplained. Many studies support the hypothesis that education has a distinctive effect on physiological processes associated with health, independently of known risk factors. Objectives In this study, we aimed to determine whether the biological embodiment of education could be part of the observed social inequalities in BC risk. We focused on biomarkers from several physiological systems examined individually, and jointly through a biological health score (BHS). Design Prospective cohort study. Setting This study, based on a subsample of the French E3N cohort, included women with biological data from four nested case–control studies. Participants The study included 3048 postmenopausal women (17% BC). Main outcome measures We first evaluated the association between educational attainmen
Source: bmjopen.bmj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment - 8 day(s) ago
New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment
Source: www.icr.ac.ukCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0
Sarah Anderson, oncology strategy lead director, Novotech, discusses the significance of triple-negative breast cancer research in the Asia-Pacific region, and the importance of clinical trial diversity in this region.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet-
In this AJMC interview, Sarah Anderson, oncology strategy lead director, Novotech, discusses the significance of triple-negative #breastcancer research in the Asia-Pacific region, and the importance of clinical trial diversity in this region. Watch now! https://t.co/UMabQBHgp6 https://t.co/pm3r7fgjag
-
-
Mashup Score: 2FDA approves Enhertu as first HER2-directed therapy for breast cancer - The Cancer Letter - 12 day(s) ago
FDA approved AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-low (IHC 1+ or IHC 2+/ISH-) or HER2-ultralow (IHC 0 with membrane staining) breast cancer, as determined by the FDA approved test, that has progressed on one or more endocrine therapies in the metastatic […]
Source: cancerletter.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2Inavolisib in Combination With Palbociclib and Fulvestrant Meets Secondary End Point in the INAVO120 Trial - 12 day(s) ago
The overall survival data were immature at the primary analysis of the study.
Source: www.pharmacytimes.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 26Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial - 18 day(s) ago
PURPOSECyclin-dependent kinase 4/6 inhibitors (CDK4/6i) combined with endocrine therapy (ET) are the standard first-line treatment for hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC); …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
Do women with higher educational attainment have a higher risk of developing breast cancer? Read the findings from a French prospective cohort: https://t.co/z74Rt5bwwg #BreastCancer https://t.co/AnBEcfVvod